Search

Data from bycaught, but otherwise presumed healthy individuals can contribute important biological data on species of cetaceans that are otherwise lacking. This study utilises data collected from systematic necropsies performed between October 1970 and May 2010 on 142 Indo-Pacific humpback dolphins (Sousa chinensis), 607 Indo-Pacific bottlenose dolphins (Tursiops aduncus), and 640 long-beaked common dolphins (Delphinus capensis) incidentally caught and drowned in the shark nets off KwaZulu-Natal, South Africa. The aim of this analysis was to: (1) determine average absolute and relative organ weights for the three taxa as baseline values for later pathological examinations; and (2) examine potential correlations with the physiology and ecology in the three genera. Body length-weight relationships were described for the three species, indicating that S. chinensis is more robust than T. aduncus, with D. capensis being the smallest species out of the three taxa. Organ weights, as a percentage of total body weight were examined for the three delphinids. Organs examined included heart, lungs and trachea, liver, kidneys, spleen, and testes. Relative heart, liver and kidney weights were significantly larger in the small-bodied, fast-swimming D. capensis, than in the slower, more coastal S. chinensis and T. aduncus, possibly reflecting differences in activity patterns between the three species. Relative lung and trachea weights were not significantly different in the three species. Combined testes weight, as a percentage of total body weight, in combination with information on group size and sexual dimorphism suggested a monogamous or extreme polygynous (harem) mating system in S. chinensis, frequent copulations in T. aduncus, and sperm competition in D. capensis. The results of the present study suggest that the relative sizes of the major organs in the three genera are a reflection of the differing life histories and ecologies of the species examined.

Co-packaged optics leads to significant power reduction by placing the electronic and photonic chiplets in a single package. An integrated electro-optical substrate made of glass with optical waveguides, through vias and electrical redistribution layers inside a single-sided cavity enables fine-line electrical routing and low-cost assembly. Existing glass and thin film technologies were evaluated and combined into a single process stream including photonic assembly. Photonic chips with silicon nitride waveguides were optically coupled to integrated low-loss (

Purpose Cardiac radioablation using stereotactic body radiation therapy is gaining popularity as a noninvasive treatment for otherwise refractory ventricular arrhythmias. As radiation oncologists might be unaccustomed to the lexicon used by cardiologists to describe the location of arrhythmogenic foci, a preliminary guide to cardiac-specific anatomy and orientation is needed to foster effective communication between the radiation oncologist and cardiology team. Methods and Materials Electrocardiogram-gated and respiratory-gated computed tomography imaging was acquired per institutional protocol. Additional relevant imaging modalities are described. The American Heart Association 17-segment model is described in detail because this framework is used frequently by cardiologists to describe the location left ventricular abnormalities. Results A step-by-step guide is provided for properly rotating the heart from standard orthogonal views obtained during radiation simulation to the cardiac-specific orientation needed to appreciate the 17-segment model. Once the proper configuration is achieved, the location of each segment is defined in detail. Conclusions This atlas serves as an introduction to the relevant anatomy and principles, and it provides a suggested approach to help delineate cardiac radioablation targets using the established American Heart Association 17-segment model.

PURPOSE Radiation dose to the neuroregenerative zone of the hippocampus has been found to be associated with cognitive toxicity. Hippocampal avoidance (HA) using intensity-modulated radiotherapy during whole-brain radiotherapy (WBRT) is hypothesized to preserve cognition. METHODS This phase III trial enrolled adult patients with brain metastases to HA-WBRT plus memantine or WBRT plus memantine. The primary end point was time to cognitive function failure, defined as decline using the reliable change index on at least one of the cognitive tests. Secondary end points included overall survival (OS), intracranial progression-free survival (PFS), toxicity, and patient-reported symptom burden. RESULTS Between July 2015 and March 2018, 518 patients were randomly assigned. Median follow-up for alive patients was 7.9 months. Risk of cognitive failure was significantly lower after HA-WBRT plus memantine versus WBRT plus memantine (adjusted hazard ratio, 0.74; 95% CI, 0.58 to 0.95; P = .02). This difference was attributable to less deterioration in executive function at 4 months (23.3% v 40.4%; P = .01) and learning and memory at 6 months (11.5% v 24.7% [ P = .049] and 16.4% v 33.3% [ P = .02], respectively). Treatment arms did not differ significantly in OS, intracranial PFS, or toxicity. At 6 months, using all data, patients who received HA-WBRT plus memantine reported less fatigue ( P = .04), less difficulty with remembering things ( P = .01), and less difficulty with speaking ( P = .049) and using imputed data, less interference of neurologic symptoms in daily activities ( P = .008) and fewer cognitive symptoms ( P = .01). CONCLUSION HA-WBRT plus memantine better preserves cognitive function and patient-reported symptoms, with no difference in intracranial PFS and OS, and should be considered a standard of care for patients with good performance status who plan to receive WBRT for brain metastases with no metastases in the HA region.

Highlights • Stereotactic radiation was used for both lung cancer primaries and brain metastases. • Oligometastatic and stage I patients achieved similar survival and local control. • Both patient groups had low toxicity rates. • Local radiation alone is effective and safe for oligometastatic lung cancer., Background There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation therapy (SBRT) and brain stereotactic radiosurgery (SRS) had favorable outcomes with local therapy. Materials and methods We reviewed a database of patients receiving lung SBRT as well as a database for brain metastasis patients treated with SRS between June 2004 and January 2016. We selected for cT1-2aN0M1 NSCLC patients with brain metastases and calculated their overall survival (OS), freedom from progression (FFP), and local control (LC) rates. Results Six patients had oligometastatic NSCLC with 1–3 synchronous brain metastases treated with lung SBRT and brain SRS. No patients received immunotherapy and two-thirds did not receive systemic therapy. Median follow-up was 9 months for the entire cohort (range, 2–95 months) and 95 months for the surviving patient. Median OS was 12.4 months (95% confidence interval [CI], 7–18 months). At 1 year, patients had 67% OS (95% CI, 29–100%), 17% FFP (95% CI, 0–46%), and 100% LC. Their brain disease had 80% 1-year LC (95% CI, 45–100%) and 53% 1-year FFP (95% CI, 5–100%). Two patients had no distant progression, two had brain progression, one had adrenal gland progression, and one had bone and liver progression. Conclusion In patients presenting with oligometastatic lung cancer limited to the brain, treatment with both lung SBRT and brain SRS achieves good LC of all sites with encouraging OS.

BACKGROUND: Patients with multiple primary lung cancers (MPLC) increasingly receive multiple courses of stereotactic body radiation therapy (SBRT). We aimed to clarify the efficacy and safety of such treatments. PATIENTS AND METHODS: We reviewed a prospective lung SBRT database for patients treated for stage I non-small cell lung cancer between June 2004 and December 2015. RESULTS: 374 patients received a single course of SBRT, 14 received synchronous SBRT, 48 received metachronous SBRT alone, and 108 received surgery and metachronous SBRT. Median follow-up was 37.0 months for survivors. Patients that received a single course had a three-year overall survival (OS) of 54.2% (95% confidence interval [CI], 48.8–59.3%), three-year freedom from progression (FFP) of 67.3% (95% CI, 60.9–72.9), and grade ≥3 toxicity of 3.5%. Compared to single-course patients, patients receiving metachronous SBRT alone and patients receiving surgery and metachronous SBRT had improved OS (79.7% [95% CI, 64.4–88.9%], P

Radiation therapy is a well-established approach for safely and non-invasively treating solid tumours and benign diseases with high precision and accuracy. Cardiac radiation therapy has recently emerged as a non-invasive treatment option for the management of refractory ventricular tachycardia. Here we summarise existing clinical and preclinical literature surrounding cardiac radiobiology and discuss how these studies may inform basic and translational research, as well as clinical treatment paradigms in the management of arrhythmias.